Product Information
NYSTATIN 100,000 UNIT/GM POWD is a generic product labeled by Mayne Pharma, priced at $0.2755 per GM under NDC 68308015260. Its NADAC has been published 645 times since Nov 28, 2013.
FDA first approved this application on Jul 15, 2004. Its Orange Book therapeutic-equivalence code is AT.
Strength
100000 [USP'U]/g
Manufacturer
Mayne PharmaNDC
68308015260
Classification
Generic
Dosage Form
POWDER
Route
TOPICAL
Effective Date
3/18/2026
Active Ingredients
NYSTATINApproval Type
Generic (ANDA)
FDA Application
ANDA065203FDA Approved
7/15/2004
TE Code
AT
On Market Since
7/15/2004
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN 100,000 UNIT/GM POWD has been published 645 times since Nov 28, 2013, and over the history we have for it it has declined 65.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2755 per GM |
|---|---|
| All-time high | $0.8367 (Apr 16, 2014) |
| All-time low | $0.1792 (Feb 22, 2023) |
| 52-week high | $0.2869 |
| 52-week low | $0.2755 |
| Median price | $0.2869 |
| Average price | $0.3760 |
| Largest weekly change | +30.5% (Feb 17, 2021) |
| Weeks tracked | 645 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-2.5%
3Y
+2.9%
5Y
+18.8%
All
-65.4%
Last surveyed Apr 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mayne Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nystatin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Polyene Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NYSTATIN 100,000 UNIT/GM POWD?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN 100,000 UNIT/GM POWD, manufactured by Mayne Pharma, is $0.2755 per GM (NDC 68308015260), effective Apr 1, 2026.
How has the price of NYSTATIN 100,000 UNIT/GM POWD changed over time?
Over the history we have for it, the NADAC for NYSTATIN 100,000 UNIT/GM POWD has declined 65.4%. It has been tracked across 645 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NYSTATIN 100,000 UNIT/GM POWD?
Since Nov 28, 2013, the NADAC for NYSTATIN 100,000 UNIT/GM POWD has ranged from a low of $0.1792 (Feb 22, 2023) to a high of $0.8367 (Apr 16, 2014), with a median of $0.2869 per GM.
Are there cheaper alternatives to NYSTATIN 100,000 UNIT/GM POWD?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN 100,000 UNIT/GM POWD, is $0.2574 per GM — about 7% below NYSTATIN 100,000 UNIT/GM POWD.
Who manufactures NYSTATIN 100,000 UNIT/GM POWD?
NYSTATIN 100,000 UNIT/GM POWD (NDC 68308015260) is labeled by Mayne Pharma, and CMS classifies it as a generic product.